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Abstract. 
 
Tyrosine phosphorylation of the high afﬁnity 
immunoglobulin (Ig)E receptor (Fc
 
e
 
RI) by the Src 
family kinase Lyn is the ﬁrst known biochemical step 
that occurs during activation of mast cells and basophils 
after cross-linking of Fc
 
e
 
RI by antigen. The hypothesis 
that specialized regions in the plasma membrane, en-
riched in sphingolipids and cholesterol, facilitate the 
coupling of Lyn and Fc
 
e
 
RI was tested by investigating 
functional and structural effects of cholesterol deple-
tion on Lyn/Fc
 
e
 
RI interactions. We ﬁnd that cholesterol 
depletion with methyl-
 
b
 
-cyclodextrin substantially re-
duces stimulated tyrosine phosphorylation of Fc
 
e
 
RI 
and other proteins while enhancing more downstream 
events that lead to stimulated exocytosis. In parallel to 
its inhibition of tyrosine phosphorylation, cholesterol 
depletion disrupts the interactions of aggregated Fc
 
e
 
RI 
and Lyn on intact cells and also disrupts those interac-
tions with detergent-resistant membranes that are iso-
lated by sucrose gradient ultracentrifugation of lysed 
cells. Importantly, cholesterol repletion restores recep-
tor phosphorylation together with the structural inter-
actions. These results provide strong evidence that 
membrane structure, maintained by cholesterol, plays a 
critical role in the initiation of Fc
 
e
 
RI signaling.
Key words: methyl-
 
b
 
-cyclodextrin • immunoglobulin 
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T
 
HE
 
 first known biochemical event in antigen stimu-
lation of mast cells and basophils is tyrosine phos-
phorylation of the 
 
b
 
 and 
 
g
 
 subunits of the high af-
finity IgE receptor (Fc
 
e
 
RI) by the Src family kinase Lyn;
however, the mechanism by which these proteins interact
is not fully understood. A common view is that this recep-
tor–kinase coupling occurs strictly via protein–protein
interactions. For example, in the transphosphorylation
model, antigen-induced cross-linking causes Lyn, which is
 
bound weakly to one receptor, to phosphorylate im-
mune  tyrosine activation motifs on a juxtaposed receptor,
thereby initiating signal transduction (Jouvin et al., 1994;
Pribluda et al., 1994). We recently presented a different
view that the plasma membrane structure plays an integral
role in facilitating coupling between Lyn and Fc
 
e
 
RI. In
particular, we proposed that Fc
 
e
 
RI tyrosine phosphoryla-
tion occurs within specialized regions in the plasma mem-
brane, enriched in sphingolipids and cholesterol (Field et
al., 1997; Sheets et al., 1999). Membrane structures of this
composition have been isolated from many cell types and
primarily characterized on the basis of their resistance to
solubilization by nonionic detergents such as Triton X-100
(TX-100)
 
1
 
 and their consequent buoyancy in sucrose den-
sity gradients. These isolated detergent-resistant mem-
branes (DRMs) (also referred to in the literature as DIGs
[detergent insoluble glycolipid domains], GEMs [gly-
colipid-enriched membranes], and membrane rafts) are
enriched in cholesterol, sphingomyelin, glycosphingolip-
ids, and saturated glycerophospholipids, as well as dually
acylated Src family kinases (e.g., Lyn, Fyn, Yes) and glyco-
sylphosphatidylinositol (GPI)-anchored proteins (for re-
view see Brown and London, 1998a; Simons and Ikonen,
1997). They are postulated to represent plasma membrane
domains that may function as centers for signal transduc-
tion and membrane trafficking, although their nature on
the cell surface is controversial (Brown and London,
1998a; Edidin, 1997).
In initial studies we found that cross-linking of Fc
 
e
 
RI in-
creases the percentage of cellular Lyn recovered in DRMs
from TX-100–lysed RBL-2H3 mast cells, suggesting that
Fc
 
e
 
RI aggregation causes an alteration of DRMs that may
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Abbreviations used in this paper:
 
 BSA/BSS, BSA-containing buffered
saline solution; DRM, detergent-resistant membrane; GPI, glycosyl-
phosphatidylinositol; HRP, horseradish peroxidase; 
 
L
 
o
 
, liquid-ordered;
M
 
b
 
CD, methyl-
 
b
 
-cyclodextrin; TfR, transferrin receptor; TX-100, Triton
X-100. 
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be involved in Fc
 
e
 
RI-mediated signaling (Field et al.,
1995). With sufficiently low concentrations of TX-100 to
lyse the cells, aggregated (but not monomeric) Fc
 
e
 
RI also
associate with DRM vesicles, and only this population of
receptors is phosphorylated upon cross-linking (Field et
al., 1997). Furthermore, fluorescence microscopy on intact
cells revealed that cross-linking of Fc
 
e
 
RI induces co-redis-
tribution with DRM components, including a GD
 
1b
 
 gangli-
oside (Pierini et al., 1996), as well as Lyn and the GPI-
anchored protein Thy-1 (Holowka, D., E.D. Sheets, and
B. Baird, manuscript in preparation), and with saturated
phospholipid analogues (Thomas et al., 1994). Together,
these results are consistent with the view that specialized
membrane domains function in cells to facilitate coupling
between aggregated Fc
 
e
 
RI and Lyn.
The detergent resistance of these membrane structures
has been hypothesized to depend upon their lipid phase
(Brown and London, 1998b). Cholesterol, which pro-
foundly affects phase behavior of lipids, was found to be a
major lipid component of isolated DRMs derived from
MDCK cells (Brown and Rose, 1992). In subsequent stud-
ies, Brown and colleagues found that model membranes
with compositions similar to DRMs are not solubilized by
TX-100, and this detergent resistance was observed to cor-
relate with cholesterol concentrations that induce forma-
tion of the liquid-ordered (
 
L
 
o
 
) phase (Schroeder et al.,
1994; Ahmed et al., 1997; Schroeder et al., 1998). This
phase results from cholesterol having a gel phase–like or-
dering effect on the saturated and near-saturated acyl
chains of glycerophospholipids and sphingolipids; yet the
lipids retain a high degree of lateral and rotational mobil-
ity, similar to lipids in the fluid liquid crystalline phase
(Brown and London, 1998a,b). The relevance of this struc-
ture for biological membranes is supported by recent elec-
tron spin resonance measurements that showed param-
eters characteristic of the 
 
L
 
o 
 
phase for DRM vesicles
isolated from RBL cells (Ge et al., 1999). Overall, these
results support the hypothesis that ordered lipid domains
coalescing on the plasma membrane after Fc
 
e
 
RI aggrega-
tion serve to co-localize Fc
 
e
 
RI and Lyn and thereby ini-
tiate receptor phosphorylation and signaling.
As reported here, we tested this hypothesis by using
methyl-
 
b
 
-cyclodextrin (M
 
b
 
CD) to selectively deplete cho-
lesterol from RBL-2H3 cells, and we investigated the func-
tional and structural effects of the M
 
b
 
CD treatment on
Fc
 
e
 
RI/Lyn interactions. This reagent has been used re-
cently for efficient removal of cholesterol from a variety of
cell types (Kilsdonk et al., 1995; Yancey et al., 1996; Chris-
tian et al., 1997; Gimpl et al., 1997; Scheiffele et al., 1997;
Friedrichson and Kurzchalia, 1998; Keller and Simons,
1998; Varma and Mayor, 1998). We find that cholesterol
depletion substantially reduces stimulated tyrosine phos-
phorylation of Fc
 
e
 
RI and other substrates in RBL cells.
Furthermore, we find that cholesterol depletion selectively
disrupts the structural interactions between aggregated
Fc
 
e
 
RI and Lyn both for DRM vesicles from lysed cells
that are isolated on sucrose gradients and for intact cells as
assessed by confocal fluorescence microscopy. When cho-
lesterol levels are repleted, these functional effects and
molecular associations are restored. These results provide
strong evidence that cholesterol is required for effective
functional coupling between aggregated Fc
 
e
 
RI and Lyn,
 
and they are consistent with an important structural role
for liquid-ordered membrane domains in this coupling.
 
Materials and Methods
 
Cholesterol Depletion and Repletion
 
RBL-2H3 cells were maintained and harvested as previously described
(Pierini et al., 1996). Mouse monoclonal IgE specific for 2,4-dinitrophenyl
(DNP) (Liu et al., 1980) was purified as previously described (Subrama-
nian et al., 1996); biotinylated and iodinated (Field et al., 1995) or FITC-
labeled (Pierini et al., 1996) IgE was used to sensitize cells in some experi-
ments. Mouse monoclonal anti-1,5-dansyl IgE was affinity purified as
previously described (Weetall et al., 1993). Other RBL cell membrane
components were labeled with AA4 mAb (a gift from Dr. Reuben Sir-
aganian, National Institutes of Health, Bethesda, MD), specific for the
 
a
 
-galactosyl GD
 
1b
 
 ganglioside derivative; OX-7 (PharMingen), specific
for the GPI-anchored protein Thy-1; and anti-Lyn (Upstate Biotechnol-
ogy, Inc., and Santa Cruz Biotechnology) as previously described (Field et
al., 1995; Pierini et al., 1996). Transferrin receptors (TfRs; CD71) were la-
beled with a monoclonal antibody from PharMingen, followed by Cy3-
goat anti–mouse 
 
g
 
 chain (Southern Biotechnology Associates).
To remove cholesterol, suspended cells (2–4 
 
3
 
 10
 
6
 
 cells/ml) were incu-
bated for 1 h at 37
 
8
 
C in the presence or absence of 10 mM M
 
b
 
CD (Sigma
Chemical Co.) in BSA-containing buffered saline solution (BSA/BSS:
20 mM Hepes, pH 7.4, 135 mM NaCl, 5 mM KCl, 1.8 mM CaCl
 
2
 
, 1 mM
MgCl
 
2
 
, 5.6 mM glucose, and 1 mg/ml BSA), then washed with BSA/BSS
before stimulation. For some experiments, cholesterol (Avanti Polar Lip-
ids) was added back to cholesterol-depleted cells (2 
 
3
 
 10
 
6
 
 cells/ml) in
BSA/BSS by incubation for 2 h at 37
 
8
 
C with indicated concentrations of
M
 
b
 
CD/cholesterol (8:1, mol/mol) complexes. These complexes were pre-
pared similarly to a previously described procedure (Racchi et al., 1997).
In brief, cholesterol in a chloroform solution was dried under nitrogen in a
glass culture tube precleaned with ethanolic KOH. An appropriate vol-
ume of sterile-filtered 300 mM M
 
b
 
CD in BSA/BSS was added to the tube,
and the resulting suspension was vortexed and bath sonicated until the
suspension clarified. The complex was then incubated in a rocking water
bath overnight at 37
 
8
 
C to maximize formation of soluble complexes.
 
In Vivo Tyrosine Phosphorylation Assays
 
Suspended RBL-2H3 cells that had been sensitized with anti-DNP IgE
(Chang et al., 1995) and cholesterol depleted/repleted or not were stimu-
lated at a density of 10
 
6
 
 cell/ml with multivalent DNP-BSA (1 
 
m
 
g/ml; Xu
et al., 1998a) at 37
 
8
 
C for indicated times, lysed by addition of 5
 
3
 
 SDS
sample buffer (50% glycerol, 0.25 M Tris, pH 6.8, 5% SDS, 0.5% brom-
phenol blue) and boiled for 5 min and centrifuged for 5 min at 13,000 
 
g
 
.
Equal numbers of cell equivalents of lysates (typically, 8 
 
3
 
 10
 
3
 
 cell equiva-
lents) were electrophoresed on 12% nonreduced SDS polyacrylamide
gels, transferred to Immobilon-P membranes (Millipore Corp.), and
probed with horseradish peroxidase–conjugated antiphosphotyrosine
(4G10-HRP; Upstate Biotechnology, Inc.). Enhanced chemiluminescence
(Pierce) was used for detection. Phosphorylation as a function of stimula-
tion time was quantified after scanning blots and analyzing with Un-Scan-
It (Silk Scientific) and Igor Pro (WaveMetrics).
 
Quantitative Measurements of Fc
 
e
 
RI
 
We determined the effect of M
 
b
 
CD on the amount of Fc
 
e
 
RI associated
with RBL-2H3 cells by two different methods. For some experiments,
biotinylated 
 
125
 
I-IgE was bound to Fc
 
e
 
RI under saturating conditions, and
these labeled cells were used to monitor the loss of IgE–Fc
 
e
 
RI complexes
after treatment with or without M
 
b
 
CD as described above. The state of
 
125
 
I-IgE released from the cells during M
 
b
 
CD treatment was assessed by
collecting the supernatants after cell pelleting (200 
 
g
 
, 5 min) and subject-
ing these to a high speed centrifugation (250,000 
 
g
 
, 45 min, 4
 
8
 
C). Gamma
counting indicated that 54% of the 
 
125
 
I-IgE was pelleted during the second
centrifugation, in contrast to only 6% of the 
 
125
 
I-IgE that could be pelleted
under these conditions for untreated cells. In another set of experiments,
Fc
 
e
 
RI were saturated with FITC-IgE, and cells were treated with or with-
out M
 
b
 
CD. Receptor-bound FITC-IgE was measured on washed cells
with steady-state fluorimetry as previously described (Xu et al., 1998b).
Examination of these cells by fluorescence microscopy in the presence or
absence of 15 mM NH
 
4
 
Cl to neutralize endosomes (Xu et al., 1998b) 
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showed no evidence for internalization of FITC-IgE after M
 
b
 
CD treat-
ment.
To examine the relationship between the density of anti-DNP IgE on
the cells and antigen-stimulated tyrosine phosphorylation, Fc
 
e
 
RI were sat-
urated with mixtures of anti-DNP IgE and antidansyl IgE in percentage
mixtures of 30:70, 50:50, and 100:0. Washed cells were stimulated with 1
 
m
 
g/ml DNP-BSA at 37
 
8
 
C for various times and tyrosine phosphorylation
was analyzed. Competition binding between each of these unlabeled anti-
bodies and FITC-labeled anti-DNP IgE was carried out under identical
conditions. With steady-state fluorimetry to quantify the amount of cell-
bound FITC-IgE, we confirmed that the percentages of anti-DNP IgE and
antidansyl IgE bound to Fc
 
e
 
RI in the tyrosine phosphorylation experi-
ments were identical to the percentages added with an uncertainty of
 
6
 
 8%. Furthermore, fluorimetry experiments with mixtures of FITC anti-
DNP IgE and unlabeled antidansyl IgE showed that DNP-BSA binding
and cross-linking induced internalization of FITC-IgE–Fc
 
e
 
RI proportion-
ally to the amount of FITC-IgE bound in the range of 30–100% occupancy
by this IgE (data not shown; Xu et al., 1998a,b).
 
Sucrose Gradients
 
Cholesterol-depleted/repleted or untreated cells were fractionated on su-
crose step gradients as previously described (Field et al., 1997), except
that the concentration of TX-100 during lysis was 0.04% instead of 0.05%.
Aliquots (200 
 
m
 
l) were removed from the top of the gradient, and 
 
g
 
-radia-
tion of biotinylated 
 
125
 
I-IgE was counted. The gradient fractions were then
pooled as indicated, boiled with SDS sample buffer, and blotted as de-
scribed above, except that the primary antibody was rabbit anti-Lyn anti-
body (Upstate Biotechnology, Inc.) and the secondary antibody was
HRP-conjugated donkey anti–rabbit Ig (Amersham Pharmacia Biotech).
To determine the location of GD
 
1b
 
 in the gradients, cells labeled with 
 
125
 
I-
AA4 and biotinylated IgE were analyzed as previously described (Field
et al., 1995). In some experiments, the pooled gradient fractions were elec-
trophoresed on 12% nonreduced SDS-acrylamide gels and subsequently
were silver stained (Daiichi Silver Stain II; Owl Separation Systems).
 
Immunodepletion of Fc
 
e
 
RI
 
Anti-DNP IgE–sensitized cells were stimulated for the indicated times
with DNP-BSA (1 
 
m
 
g/ml) and lysed on ice with TX-100 lysis buffer [10 mM
Tris, pH 8.0, 50 mM NaCl, 1 mM Na
 
3
 
VO
 
4
 
, 30 mM sodium pyrophosphate,
10 mM sodium glycerophosphate, 0.02 U/ml aprotinin, 0.01% NaN
 
3
 
, 1 mM
4-(2-aminoethyl)benzenesulfonyl fluoride, and 0.2% TX-100] followed by
addition of 10 
 
m
 
M DNP-aminocaproyl-
 
L
 
-tyrosine, as previously described
(Harris et al., 1997). After centrifugation at 13,000 
 
g
 
 for 5 min to remove
insoluble material, lysates were incubated with or without 20 
 
m
 
g/ml rabbit
anti-IgE (Menon et al., 1984). After incubation with protein A–agarose
beads (Pierce), samples were centrifuged to pellet the beads and superna-
tants were removed, boiled in SDS sample buffer, electrophoresed, and
blotted with 4G10-HRP as described above. Rabbit anti-IgE/IgE–Fc
 
e
 
RI
complexes are bound to the protein A–agarose, which result in selective
depletion of the Fc
 
e
 
RI 
 
b
 
 and 
 
g
 
 bands.
 
Degranulation Assays
 
The degranulation response that occurs after stimulation with the antigen
DNP-BSA or the calcium ionophore A23187 (Calbiochem-Novabiochem)
for 1 h at 37
 
8
 
C was carried out as described previously (Harris et al., 1997),
except that cells were treated with or without M
 
b
 
CD immediately before
stimulation.
 
Confocal Immunofluorescence Microscopy
 
Cells sensitized with FITC-IgE were treated with or without M
 
b
 
CD, then
washed and incubated with cytochalasin D (1 
 
m
 
g/ml) for 5 min at room
temperature to prevent antigen-stimulated IgE–Fc
 
e
 
RI internalization and
to sustain Lyn co-redistribution with patched IgE–Fc
 
e
 
RI at the cell sur-
face. The cells were then stimulated with 1.7 
 
m
 
g/ml DNP-BSA at room
temperature for 20 min and subsequently fixed with cold methanol for
Lyn labeling or with formaldehyde for GD
 
1b
 
 or TfR labeling as previously
described (Pierini et al., 1996). Confocal fluorescence microscopy was per-
formed as previously described (Pierini et al., 1996). Cross correlation
analysis of the co-redistribution of Lyn or TfR with antigen–cross-linked
FITC-IgE–Fc
 
e
 
RI were carried out on equatorial images of individual cells
using a computational procedure similar to that previously described
(Stauffer and Meyer, 1997). Peak values can be calculated from this analy-
 
sis to a correlation coefficient (
 
r
 
) (Eq. 1; Barlow, 1989), and these values
were averaged for 7–13 cells from each sample for numerical comparison
of the degree of co-redistribution.
 
(1)
 
In Eq. 1, 
 
x
 
i
 
 and 
 
y
 
i
 
 are the intensities at each equatorial point of the
FITC and Cy3 fluorescence, respectively, and 
 
, 
 
x
 
 . 
 
and 
 
, 
 
y
 
 . 
 
are the
corresponding average values.
 
Lipid Extractions and Analyses
 
RBL-2H3 cells were depleted of cholesterol (or not) and repleted (or not)
as described above. After treatment, the cells were washed with BSA/
BSS, and then resuspended in methanol. The cell lysate was homogenized
with a Duall ground glass tissue grinder, transferred to an ethanolic KOH-
cleaned glass vial, and an equal volume of chloroform was added, fol-
lowed by vigorous vortexing and probe sonication. The samples were
rocked overnight at room temperature, then centrifuged at 800 
 
g
 
 for 5
min, and the supernatants were transferred to a new glass vial. Chloro-
form/methanol (1:1, vol/vol) was added to the pellets and the suspension
was vortexed vigorously and centrifuged as described above. Supernatants
consisting of the total lipid extracts were combined and stored under ni-
trogen at 2208C.
The extent of cholesterol depletion or repletion was measured using a
colorimetric cholesterol oxidase assay (Boehringer Mannheim) that quan-
tifies total free cholesterol. Total lipid extracts from paired samples of
MbCD-treated and untreated cells were assayed simultaneously in these
determinations. Thin layer chromatography of the total lipid extracts was
carried out on silica gel 60 plates (EM Science) as previously described
(Cartwright, 1993), with iodine detection. The developing solvent for po-
lar lipids was chloroform/methanol/glacial acetic acid/water (60:50:1:4,
vol/vol), and for neutral lipids, hexane/diethyl ether/glacial acetic acid (90:
10:1, vol/vol) (Cartwright, 1993).
Results
Cholesterol Depletion Inhibits Antigen-stimulated 
Tyrosine Phosphorylation of FceRI
Because cholesterol is a critical component of liquid-
ordered DRMs, we investigated whether reduction of the
cholesterol content of the RBL-2H3 mast cells affects the
tyrosine phosphorylation of FceRI b and g subunits. For
this purpose, we incubated the cells with 10 mM MbCD
for 1 h at 378C to deplete cellular cholesterol before stimu-
lation with multivalent antigen. Fig. 1 a shows a represen-
tative antiphosphotyrosine Western blot of lysates from
control and MbCD-treated cells that have been stimulated
with an optimal dose of antigen, DNP-BSA, for 0–30 min
at 378C. For the control cells, stimulated tyrosine phosphor-
ylation is maximal after 2 min of stimulation with 1 mg/ml
DNP-BSA, and then declines over time as previously re-
ported (Pribluda and Metzger, 1992; Xu et al., 1998a). For
the MbCD-treated cells, there is a substantial reduction in
stimulated tyrosine phosphorylation in all bands detected,
including the b and g subunits of FceRI that are readily
observed under these conditions when the 4G10 mAb is
used to detect phosphotyrosine. Fig. 1 b quantifies the
time course of tyrosine phosphorylation of FceRI b in this
experiment. By this method of analysis, we found that
maximal FceRI b tyrosine phosphorylation is inhibited 95 6
4% by pretreatment with MbCD in six separate experi-
ments under these optimal conditions. The identity of
FceRI b and g in the antiphosphotyrosine blots of whole
r
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cell lysates was confirmed by specific immunodepletion of
these bands with anti-IgE (Fig. 1 c).
To further characterize the cells under conditions of
MbCD treatment, we determined that untreated cells con-
tain 6.7 6 0.7 nmol free cholesterol/106 cells (n 5 5), and,
after incubation with 10 mM MbCD at 378C for 1 h, the
amount of free cholesterol was determined to be 2.7 6 1.0
nmol/106 cells (n 5 5). Thus, the fraction of free choles-
terol remaining after treatment is 0.40 6 0.15 as compared
with untreated cells, consistent with previously described
levels of cholesterol depletion for a variety of cell types
under similar conditions (Kilsdonk et al., 1995; Yancey et al.,
1996; Christian et al., 1997; Gimpl et al., 1997; Scheiffele et al.,
1997; Friedrichson and Kurzchalia, 1998; Keller and Si-
mons, 1998; Varma and Mayor, 1998). TLC analysis of cel-
lular lipid extracts showed that there was no detectable
difference in phospholipid composition before and after
MbCD treatment, and this is also consistent with previous
reports from other laboratories for other cell types (Kils-
donk et al., 1995; Yancey et al., 1996; Christian et al., 1997;
Gimpl et al., 1997). In particular, we found that the
amounts of phosphatidylethanolamine, phosphatidylcho-
line, and sphingomyelin present in the total lipid extracts
from MbCD-treated cells were not obviously different
from untreated cell lipids (data not shown). The amounts
of two other unidentified lipid species (one polar lipid spe-
cies and one neutral lipid species) observed with TLC also
were unaffected by MbCD treatment.
To further investigate the basis for the dramatic reduc-
tion in tyrosine phosphorylation of FceRI b, we measured
the amount of FceRI before and after MbCD treatment
using  125I-IgE. Under our optimal conditions for inhibition
of tyrosine phosphorylation (10 mM MbCD for 1 h at
378C), we observed a 70 6 6% (n 5 6) loss of receptor-
bound IgE from the cells that could be recovered in the su-
pernatants of the cell washes after MbCD treatment. Simi-
larly, 64 6 7% (n 5 2) of the ganglioside GD1b was lost
from the cells due to MbCD treatment as detected using
125I-AA4 mAb. The loss of FceRI is probably due to vesi-
cle shedding caused by the MbCD treatment because a
substantial fraction of 125I-IgE in the post-wash superna-
tant after MbCD treatment can be pelleted by high speed
centrifugation as membrane vesicles that are detectable by
phase contrast microscopy (data not shown).
In steady-state fluorescence measurements of FITC-IgE
bound to MbCD-treated cells, 65 6 10% (n 5 3) IgE–
FceRI loss was observed. Qualitatively consistent results
were visualized with FITC-IgE and Cy3-AA4 in fluores-
cence microscopy of labeled cells, and a similar reduction
in the cell surface expression of the GPI-anchored protein
Thy-1 was also observed (data not shown). Despite these
substantial reductions in FceRI and the outer leaflet mark-
ers for DRMs in these cells after MbCD treatment, the
plasma membrane expression of Lyn was only modestly
reduced as assessed from fluorescence microscopy and
Western blot analysis of sucrose gradient fractions (see be-
low). Silver-stained polyacrylamide gels of RBL cell ly-
sates showed no significant alterations in the amounts or
composition of proteins detected in this manner (data not
shown).
These results suggest that the inhibition of antigen-stim-
ulated tyrosine phosphorylation is due in part to a reduc-
tion in the amount of FceRI available for phosphorylation
in the MbCD-treated cells. To assess the magnitude of this
effect, we determined the relationship between FceRI ty-
rosine phosphorylation and the effective concentration of
Figure 1. Effects of cholesterol depletion on antigen-stimulated
tyrosine phosphorylation. (a) Tyrosine phosphorylation of whole
cell lysates. IgE-sensitized RBL-2H3 cells treated with (1) or
without (2) 10 mM MbCD for 1 h at 378C were washed and stim-
ulated with 1 mg/ml DNP-BSA at 378C for the indicated times,
then lysed with SDS sample buffer. Equal numbers of cell equiv-
alents (8,000/lane) were Western blot analyzed and probed with
antiphosphotyrosine. (b) Quantitation of FceRI b tyrosine phos-
phorylation. The blot shown in a was scanned and absorbances of
the b band were measured. Open and closed circles denote un-
treated and MbCD-treated cells, respectively. (c) Immunodeple-
tion of IgE–FceRI. RBL-2H3 cells were stimulated as in a and
lysed with TX-100 lysis buffer. Soluble lysates were incubated in
the presence or absence of rabbit anti-IgE followed by protein
A–agarose and centrifugation to immunodeplete IgE–FceRI.
Protein A–agarose supernatants (equal cell equivalents) were an-
alyzed by Western blot as in a.Sheets et al. Cholesterol in FceRI Signaling 881
this receptor in the plasma membrane by comparing the
amount of FceRI b tyrosine phosphorylation for cells in
which 30% of the receptors were occupied by anti-DNP
IgE, and 70% were occupied by anti-1,5-dansyl IgE, which
does not bind DNP ligands (Weetall et al., 1993; see Mate-
rial and Methods). Using the same conditions for stimula-
tion and analysis as was used for the MbCD-treated cells,
we determined that at the time point for maximal stimula-
tion DNP-BSA caused 66% (n 5 2) less tyrosine phos-
phorylation of FceRI b for the cells occupied with 30%
anti-DNP IgE compared with those occupied with 100%
anti-DNP IgE. Likewise, when FceRI on cells were occu-
pied by 50% anti-DNP IgE, DNP-BSA caused 41% (n 5
2) less tyrosine phosphorylation of FceRI b than those oc-
cupied with 100% anti-DNP IgE. Assuming that this ap-
proximately proportional relationship between receptor
number and b phosphorylation is valid for the MbCD-
treated cells over this range of anti-DNP IgE densities,
then the expected reduction in tyrosine phosphorylation
of FceRI b due to 70% loss of FceRI should be z70%.
Thus, the actual reduction in this value (95 6 4%) repre-
sents an 83% inhibition of the stimulated FceRI b tyrosine
phosphorylation expected for the amount of cross-linked
receptors present.
Because of the nearly complete inhibition of stimulated
FceRI tyrosine phosphorylation caused by MbCD-medi-
ated cholesterol depletion, we examined the effects of this
treatment on cellular degranulation as measured by re-
lease of b-hexosaminidase. Fig. 2 summarizes the results
from three separate experiments and shows that choles-
terol depletion does not significantly inhibit degranulation
stimulated by an optimal dose of antigen. Furthermore,
cholesterol depletion actually enhances the amount of de-
granulation observed in response to stimulation by the
Ca21 ionophore, A23187, without altering the amount of
b-hexosaminidase released in unstimulated cells. These re-
sults indicate that reduction in cellular cholesterol en-
hances one or more of the downstream events that follow
Ca21 elevation and lead to degranulation. They also dem-
onstrate that cholesterol depletion under these conditions
is not cytotoxic. As seen in Fig. 1, tyrosine phosphoryla-
tion of FceRI is usually inhibited more strongly than stim-
ulated phosphorylation of some other substrates (e.g., the
stimulated bands in the range of 70–100 kD) that are
known to be dependent on activation of the tyrosine ki-
nase Syk (Zhang et al., 1996). These results indicate that
relatively small amounts of stimulated tyrosine phos-
phorylation can result in substantial degranulation re-
sponses in the MbCD-treated cells. Consistent with this,
stimulation of maximal degranulation requires effective
cross-linking of only z10% of the IgE receptors on un-
treated RBL-2H3 cells (Fewtrell, 1985).
Cholesterol Depletion Disrupts the Interactions of 
Cross-linked IgE–FceRI and Lyn with DRM Vesicles
To determine the importance of cholesterol in DRM inter-
actions, we examined the distributions of IgE–FceRI and
Lyn across sucrose gradients of cholesterol-depleted or
untreated RBL cells. As previously demonstrated for un-
treated cells (Field et al., 1997), monomeric IgE–FceRI
(Fig. 3 a, d) is found predominantly in the 40% sucrose re-
gion of the gradient where cytoplasmic and detergent-
solubilized membrane proteins are characteristically ob-
served, and a large percentage of cross-linked IgE–FceRI
(Fig. 3 a, s) is located in the low density region of the gra-
dient where DRM vesicles are found (Field et al., 1997;
Scheiffele et al., 1997; Wolf et al., 1998). After MbCD
treatment, monomeric IgE–FceRI (Fig. 3 a, j) is located
in the 40% sucrose region, similar to those in the un-
treated cells. However, cross-linked IgE–FceRI (Fig. 3 a,
h) no longer float to the DRM region, but rather appear
in the 50–60% sucrose region where aggregates of IgE–
FceRI characteristically locate in the absence of interac-
tions with DRMs (Field et al., 1997). These results are rep-
resentative of four experiments, and they show that z60%
reduction in cholesterol almost completely prevents the
association of cross-linked IgE–FceRI with DRMs.
As shown in Fig. 3 b (top), the distribution of Lyn in the
gradient fractions of stimulated (1 sAv) and unstimulated
(2 sAv) cells that were not treated with MbCD is qualita-
tively similar to that observed by Field et al. (1995), who
used higher concentrations of TX-100. In the present ex-
periments, it is notable that the p56 isoform of Lyn is se-
lectively enriched in the low density, DRM region of the
gradient (fractions 4–9), whereas the p53 isoform is lo-
cated predominately in the 40% sucrose region (fractions
10–18). After cholesterol depletion, Lyn no longer local-
izes in the low density region of the gradient for both stim-
ulated and unstimulated cells, whereas the distribution of
p53 Lyn in the 40% sucrose region remains essentially un-
changed from the untreated cells (Fig. 3 b, middle). In the
cholesterol-depleted cells, it appears that p56 Lyn is rela-
tively enriched in the gradient pellet (bottom fraction),
both for the stimulated and the unstimulated cells. Over-
all, the total amount of Lyn detected in the gradients is
only moderately reduced in the MbCD-treated cells com-
pared with untreated control cells.
The loss of both aggregated FceRI and Lyn from the low
density region of the gradient raises the question of
whether DRMs are disrupted entirely in the cholesterol-
depleted cells. To address this question, we investigated
the distribution of other DRM markers in sucrose gradi-
ents after lysis of cholesterol-depleted cells. As shown in
Fig. 3 c, AA4-labeled GD1b from cholesterol-depleted
cells is found almost completely in the low density region
Figure 2. Effects of MbCD
treatment on degranulation
of IgE-sensitized RBL-2H3.
Cells pretreated with MbCD
as in Fig. 1 a (hatched bars)
or untreated controls (white
bars) were assessed by the
release of b-hexosamini-
dase. Cells were incubated
with buffer alone (spontane-
ous), 100 ng/ml DNP-BSA,
or 0.7 mM A23187 for 1 h at
378C;  b-hexosaminidase in
the supernatant was measured as a percentage of total b-hex-
osaminidase. Bars represent mean 6 SD (n 5 duplicate samples
in three independent experiments).The Journal of Cell Biology, Volume 145, 1999 882
of the gradients, indicating that DRMs still exist in some
form after z60% cholesterol depletion. The shift in GD1b
distribution to a slightly higher density after cholesterol
depletion suggests an increase in the protein/lipid ratio,
consistent with the substantial loss of cholesterol, a major
lipid component of the DRM (Brown and Rose, 1992).
These same trends are observed for both stimulated (Fig. 3
c, open symbols) and unstimulated (Fig. 3 c, closed sym-
bols) cells. Another DRM marker, the GPI-anchored pro-
tein Thy-1 (Dráberová and Dráber, 1993; Field et al., 1995;
Surviladze et al., 1998), localizes similarly to GD1b in the
sucrose gradients before and after cholesterol depletion
(data not shown). These results indicate that 60% choles-
terol depletion can prevent the interactions of some pro-
teins (FceRI and Lyn) with DRMs without eliminating
DRM structure.
Cholesterol Depletion Prevents the Redistribution of 
Lyn with Cross-linked IgE–FceRI on Intact Cells
To evaluate how cholesterol depletion affects FceRI on in-
tact cells, we used confocal fluorescence microscopy to ex-
amine the redistributions of Lyn and GD1b with cross-
linked IgE–FceRI. Representative images in Fig. 4, a and
b, show that both monomeric IgE–FceRI (left panels) and
Lyn (right panels) are uniformly distributed in the plasma
membrane in the absence and presence of MbCD, respec-
tively. When IgE–FceRI is aggregated by antigen at 228C
for 20 min, small patches of these are formed, and these
patches often cluster together on one side of the cell. As
see in Fig. 4 c, the concentration of Lyn is enhanced in
these regions of patched receptors in the absence of
MbCD treatment. For MbCD-treated cells, IgE–FceRI
also redistributes into patches after aggregation by antigen
(Fig. 4 d, left), indicating that lateral mobility is not im-
peded by cholesterol depletion; however, Lyn does not re-
distribute with IgE–FceRI under these conditions (Fig. 4
d). As indicated in the first line of Table I, these differ-
ences are statistically significant when quantified by cross
correlation analysis of multiple cells. Thus, cross-link–
dependent interactions between FceRI and Lyn on the cell
surface are largely prevented by cholesterol depletion,
consistent with the loss of interactions of these proteins
with DRMs in the sucrose gradient analyses of lysed cells
described above.
Fig. 4 e shows that, as previously observed (Pierini et al.,
1996), cross-linking of IgE–FceRI at the cell surface results
in co-redistribution of the GD1b ganglioside that is labeled
by Cy3-AA4 mAb. For MbCD-treated cells, we find that
co-redistribution of this outer leaflet DRM marker with
cross-linked IgE–FceRI is reduced compared with control
cells but not completely disrupted as was the case for Lyn.
Fig. 4 f shows an example of this variability, in which one
cell exhibits partial co-redistribution of the labeled gangli-
Figure 3. Molecular distributions of IgE–FceRI, Lyn, and GD1b on sucrose density
gradients. (a) IgE–FceRI distributions. Shown are representative sucrose gradient re-
sults in which cells were sensitized with biotinylated 125I-IgE (b-125I-IgE) and either
cross-linked with 10 nM streptavidin (sAv, open symbols) for 5 min at 378C or not
cross-linked (closed symbols). Cells were then lysed with cold TX-100 lysis buffer
containing 0.040% TX-100, loaded onto sucrose step gradients, and analyzed. Before
cross-linking with sAv (or not), cells were incubated: (1) without MbCD for 1 h at
378C, then subsequently for 2 h at 378C in the absence of MbCD or cholesterol–
MbCD (untreated; circles); (2) with 10 mM MbCD for 1 h at 378C, followed by a sub-
sequent treatment with 3 mM MbCD for 2 h at 378C (depleted; squares); or (3) with 10
mM MbCD for 1 h at 378C, followed by cholesterol/MbCD (3 mM MbCD; MbCD/
cholesterol, 8:1, mol/mol) for 2 h at 378C (repleted; triangles). (b) Lyn distributions.
Equal amounts of sucrose gradient fractions pooled as indicated were loaded onto
nonreducing SDS polyacrylamide gels and immunoblotted for Lyn. Top, untreated
cells; middle, cholesterol-depleted cells; and bottom, cholesterol-repleted cells as de-
scribed in a. Note that the fraction denoted bottom includes the pellet. (c) GD1b dis-
tributions. RBL cells sensitized with biotinylated IgE were labeled with 125I-AA4
(anti-GD1b), cross-linked or not with sAv, lysed, and subjected to sucrose density gradient analysis as in a. Distributions of GD1b from
cells stimulated with sAv as in a are denoted by open symbols and those from unstimulated cells are denoted by closed symbols. Circles
indicate untreated cells, and squares indicate cells that had been treated with 10 mM MbCD for 1 h.Sheets et al. Cholesterol in FceRI Signaling 883
oside, and the other shows a complete lack of co-redistri-
bution with patched IgE–FceRI. Under these conditions,
#20% of the cells exhibited detectable co-redistribution
of labeled ganglioside, whereas no detectable co-redistri-
bution of Lyn with IgE–FceRI patches was observed.
From these results, it appears that the interaction between
Lyn and FceRI is more sensitive to cholesterol depletion
than is the interaction between the ganglioside and FceRI
in the intact cells, although both are substantially pre-
vented. The difference observed may be related to the
greater sensitivity of the Lyn–DRM interactions than
GD1b–DRM interactions, as shown in Fig. 3 (see Discus-
sion).
As a further control, we compared the distribution of
the transferrin receptor (CD71) to FITC-IgE–FceRI cross-
linked under the same conditions as above. Previous stud-
ies showed that this transmembrane protein does not asso-
ciate with isolated DRMs (Melkonian et al., 1999), nor
does it co-redistribute with other DRM-associated pro-
teins when simultaneously but separately cross-linked on
BHK and Jurkat T cells (Harder et al., 1998). As seen in
Fig. 4, g and h, TfRs do not co-redistribute with cross-
linked IgE–FceRI, and they remain evenly distributed
around the periphery of the cell, often in tiny clusters that
may reflect interactions with coated pits. Quantitative
analysis of the cross correlation of TfR with cross-linked
IgE–FceRI show no appreciable colocalization between
these molecules whether or not the cells have been de-
pleted of cholesterol (see Table I). These results support
the significance of the co-redistribution of Lyn with cross-
linked IgE–FceRI described above, as well as its inhibition
by cholesterol depletion with MbCD.
Figure 4. Immunofluorescence
of the cellular distributions of
FceRI, Lyn, GD1b, and TfRs.
Each panel consists of paired
confocal fluorescence images
of FITC-anti-DNP IgE–
FceRI on the left side and the
indicated Cy3-labeled pro-
teins on the right side. Panels
a, c, e, and g show cells not
pretreated with MbCD, and
panels b, d, f, and h show cells
pretreated with 10 mM
MbCD before IgE–FceRI
cross-linking by antigen (c–h)
or uncross-linked (a and b).
a–d are paired images of IgE–
FceRI and Lyn, e–f are of
IgE–FceRI and GD1b, and g–h
are of IgE–FceRI and TfRs.
Arrows indicate regions of co-
redistribution of Lyn (c) or
GD1b (e and f) with patched
IgE–FceRI. Bars, 10 mm.The Journal of Cell Biology, Volume 145, 1999 884
Cholesterol Repletion Restores FceRI Tyrosine 
Phosphorylation Together with the Association of 
Cross-linked FceRI and Lyn with DRMs
To investigate the reversibility of cholesterol effects on the
functional and structural interactions of FceRI with Lyn,
we restored cholesterol levels in MbCD-treated cells by
incubating them with cholesterol–MbCD complexes. The
efficiency of repletion is dependent upon the incubation
period of the cells with the complex, the molar ratio of
cholesterol to MbCD, and the final concentration of
MbCD (Christian et al., 1997; Sheets, E.D., unpublished
results). To optimize repletion, we used several dilutions
of cholesterol–MbCD complexes prepared as described in
Materials and Methods. In our sequential depletion/reple-
tion experiment, cells were initially left untreated (control
samples) or incubated with MbCD to lower cholesterol
levels as described above. During the second step, the cells
were incubated for 2 h at 378C at the indicated dilution of
cholesterol/MbCD, 3 mM MbCD only, or buffer only. We
found that (a) the cholesterol levels of cells depleted by
exposure to MbCD in the first step did not change during
the subsequent incubation in the absence of MbCD; (b)
the presence of 3 mM of MbCD during the second step
also did not cause additional cholesterol depletion, nor did
it alter the distribution of IgE–FceRI in the sucrose gradi-
ents; and (c) under optimal conditions of cholesterol reple-
tion used (3–6 mM MbCD; 8:1, mol/mol MbCD/choles-
terol), the cholesterol content of the repleted cells was
3.0–3.5-fold higher than that in the untreated control cells.
Furthermore, TLC analyses of total lipid extracts indi-
cated that cholesterol was the only lipid that changed de-
tectably during the depletion/repletion treatments (data
not shown).
As shown in Fig. 5, repletion of cholesterol in MbCD-
treated cells results in partial restoration of antigen-stimu-
lated tyrosine phosphorylation. In the experiment shown,
maximal recovery of stimulated tyrosine phosphorylation
of FceRI b and other bands was achieved when 1:50 dilu-
tion of the preformed 8:1 MbCD/cholesterol complexes
was used to give a final concentration of 6 mM MbCD
during the repletion step (Fig. 5, lane 10). As seen in Fig.
5, lane 6, cells that had been treated with MbCD alone
during both the depletion and repletion steps have no de-
tectable b phosphorylation, and only a very small amount
of stimulated tyrosine phosphorylation is seen in the
higher molecular weight bands. Similar results to these
were obtained in three separate experiments. Under the
conditions of cholesterol depletion/repletion, loss of IgE–
FceRI was determined to be 77 6 4% (n 5 5), and, based
upon the proportional relationship between receptor num-
ber and b phosphorylation (above), this leads us to expect
that optimal restoration of FceRI  b phosphorylation
should be z23% of the stimulated control in Fig. 5, lane 2.
The somewhat smaller restoration that is apparent (Fig. 5,
lanes 10 and 12) suggests that other factors, such as the
loss of other outer-leaflet DRM components during cho-
lesterol depletion noted above, may reduce the maximum
restoration achievable (see Discussion).
Repletion of cholesterol also results in restoration of
cross-link–dependent association of IgE–FceRI with iso-
lated DRMs. When lysates of cholesterol-repleted cells
are analyzed on sucrose gradients, cross-linked IgE–FceRI
(Fig. 3 a, n) migrates to the low density sucrose region,
whereas uncross-linked IgE–FceRI (Fig. 3 a, m) is found
in the 40% sucrose region, similar to the gradient distri-
butions from control cells (Fig. 3 a, s and d). Cross-
linked IgE–FceRI from cholesterol-repleted cells migrate
at slightly lower densities in the sucrose gradients than this
complex in the control cells, suggesting that the average
density of DRMs in repleted cells is lower than in control
cells, possibly due to a decrease in the protein/lipid ratio
resulting from an increased cholesterol content. Further-
more, as shown in Fig. 3 b (bottom), p56 Lyn also migrates
to the low density region of the gradient (fractions 1–6) af-
ter cholesterol repletion in cells with both cross-linked and
uncross-linked FceRI. These results, in parallel with the
restoration of stimulated FceRI tyrosine phosphorylation
(Fig. 5), provide strong evidence that cholesterol is impor-
tant for functional coupling of FceRI with Lyn and for
their mutual association with DRMs.
Discussion
Our results demonstrate that cholesterol plays a critical
role in the initial step of FceRI signaling: antigen-stimu-
Table I. Cross Correlation Analysis of the Co-redistribution of 
Lyn or TfR with Antigen–cross-linked FITC-IgE–FceRI
2MbCD
r n
1MbCD
r n
IgE/Lyn 0.67 6 0.09 12 0.29 6 0.16 13
IgE/TfR 0.25 6 0.16 7 0.15 6 0.24 9
Quantitative analyses were carried out on fluorescent intensity profiles of equatorial
images of individual cells as described in Materials and Methods. The peak values for
each cross correlation plot (Eq.1) were averaged to yield a correlation coefficient (r)
for numerical comparison of the degree of co-redistribution; 1 corresponds to com-
plete co-localization. The correlation coefficients are reported as mean 6 SD, and n is
the number of individual cells analyzed.
Figure 5. Tyrosine phosphorylation of FceRI before and after
cholesterol depletion/repletion. IgE-sensitized cells were sequen-
tially treated with (1) or without (–) 10 mM MbCD for 1 h at
378C, then for 2 h at 378C with 3 mM MbCD (*) (lanes 5 and 6),
with 300 mM MbCD/cholesterol (8:1, mol/mol) diluted as indi-
cated (†) (lanes 7–12), or with buffer alone (lanes 1–4). Washed
cells were stimulated for 2 min with (1) or without (2) 1 mg/ml
DNP-BSA at 378C, then lysed and analyzed by antiphosphoty-
rosine Western blot analysis as described for Fig. 1 a.Sheets et al. Cholesterol in FceRI Signaling 885
lated tyrosine phosphorylation of this receptor by the Src
family tyrosine kinase Lyn. In parallel with loss of this
stimulated phosphorylation (Fig. 1), reduction of cellular
cholesterol by MbCD causes the loss of association of
both Lyn and cross-linked FceRI with DRMs isolated af-
ter cell lysis by TX-100 (Fig. 3). Restoration of the choles-
terol content of the depleted cells using preformed choles-
terol–MbCD complexes restores the association of Lyn
and cross-linked IgE–FceRI with DRMs (Fig. 3) and also
causes partial restoration of antigen-stimulated tyrosine
phosphorylation in the cells (Fig. 5). These results support
the hypothesis that interactions of cross-linked IgE–FceRI
with DRMs are important for the initial coupling of FceRI
and Lyn that results in receptor phosphorylation. On the
cell surface, the association of Lyn with aggregated IgE–
FceRI is lost as the result of cholesterol depletion (Fig. 4),
indicating that the interactions detected in isolated DRMs
are relevant to those occurring in intact cells. Further-
more, these microscopy results argue against a direct inter-
action of cross-linked FceRI with Lyn as the basis for asso-
ciation of receptors with DRMs, and they support the view
that the Lo structure of the plasma membrane is important
for FceRI–Lyn interactions.
An initially surprising finding in our studies is the appar-
ently selective loss of FceRI and outer leaflet plasma
membrane components of DRMs due to cholesterol de-
pletion by MbCD. As indicated by Western blot analysis
and fluorescence microscopy, there is a smaller loss of Lyn
due to cholesterol depletion, and there is no detectable
loss of other cellular proteins by silver stain analysis of
whole cell lysates (data not shown). The mechanism by
which cholesterol depletion causes this selective loss is not
yet known, but it is interesting to speculate that vesicles
containing these components may pinch off from the cells
in a mechanism that depends on their local structural envi-
ronment in the plasma membrane. In a recent study by
Ilangumaran and Hoessli (1998), a similar preferential re-
lease of DRM components by MbCD treatment was char-
acterized in lymphocytes and endothelial cells, and evi-
dence for release of these components in membrane
vesicles was described. Our results suggest that FceRI may
preferentially associate with DRM components on intact
cells even in the absence of receptor cross-linking. Consis-
tent with this, Basciano et al. showed that pre-binding of
AA4 mAb or its Fab fragment to the a-galactosyl GD1b
antigen on RBL-2H3 cells can effectively inhibit the sub-
sequent binding of IgE to FceRI (Basciano et al., 1986). By
varying the cell surface density of antigen-specific IgE in
the range of 30–100%, we show that the loss of FceRI due
to cholesterol depletion cannot account for the nearly
complete inhibition of FceRI tyrosine phosphorylation
that is observed in these cells. Furthermore, the partial
restoration of antigen-stimulated tyrosine phosphoryla-
tion without an increase in FceRI expression after choles-
terol repletion strengthens the evidence that cellular cho-
lesterol critically regulates the coupling of the remaining
FceRI and Lyn.
An important observation by fluorescence microscopy
is that cholesterol depletion does not prevent antigen-
dependent aggregation of IgE–FceRI on the cell surface,
even though it prevents the co-redistribution of Lyn and
inhibits stimulated tyrosine phosphorylation. We previ-
ously showed that the cholesterol-binding polyene antibi-
otic, filipin, prevents anti-IgE–mediated patching of IgE–
FceRI (Feder et al., 1994), indicating that it may prevent
aggregation of the receptor necessary to initiate signaling.
Unlike MbCD, which extracts cholesterol into a water-sol-
uble complex that can be washed away, filipin forms com-
plexes with cholesterol in the membrane that appear to re-
strict lateral diffusion of at least some membrane proteins,
making this reagent less useful for studying the role of
cholesterol in signaling by receptors that must aggregate in
response to their ligands to be effective. The rapidity with
which MbCD can reduce cell cholesterol by substantial
amounts without significantly compromising cell integrity,
as evidenced by our degranulation results, and the capac-
ity to restore stimulated tyrosine phosphorylation by rein-
troduction of cholesterol via MbCD complexes, make this
an extremely valuable tool for investigating the role of
cholesterol in a wide variety of receptor systems.
Recent studies used MbCD to investigate the role of
cholesterol in signaling by other receptors. Pike and Miller
(1998) showed that cholesterol depletion by MbCD inhib-
its EGF- and bradykinin-stimulated phosphatidylinositol
turnover, which can be restored by cholesterol repletion
with MbCD–cholesterol complexes. These receptors be-
long to the families of intrinsic tyrosine kinase receptors
and G protein–coupled receptors, respectively, suggesting
the potentially general importance of cholesterol and the
Lo structure it confers on the plasma membrane in medi-
ating receptor signaling. Interestingly, cholesterol deple-
tion by MbCD does not inhibit EGF-stimulated tyrosine
phosphorylation of its receptor (Pike, L.J., Y. Liu, K.N.
Chung, and J.A. Heuser. 1998. FASEB J. 12:A1278 [ab-
str.]), which probably occurs via a transphosphorylation
mechanism (Weiss and Schlessinger, 1998). Rather, cho-
lesterol depletion appears to affect the compartmentaliza-
tion of phosphatidylinositol 4,5-bisphosphate, the primary
phospholipase C substrate in the plasma membrane, as re-
vealed by its reduced localization with DRMs in sucrose
gradients (Pike and Miller, 1998). In contrast, our results
with IgE receptors indicate a role for cholesterol in the ini-
tial signaling step in which these receptors are phosphory-
lated by Lyn, and this finding may have general relevance
for other receptors that function by interacting with Src
family kinases. Indeed, Xavier et al. (1998) and Moran and
Miceli (1998) showed that pretreatment of T cells with
MbCD inhibits T cell receptor for antigen-mediated Ca21
mobilization and tyrosine phosphorylation, respectively,
providing evidence for an important role for cholesterol in
the function of this related multichain immune recognition
receptor family member.
Our degranulation results (Fig. 2) suggest that normal
levels of cholesterol may negatively regulate downstream
signaling or the exocytotic process in the RBL-2H3 cells.
The enhancement of degranulation stimulated by Ca21
ionophore, as well as the lack of inhibition of antigen-stim-
ulated degranulation, despite the dramatic inhibition of ty-
rosine phosphorylation by cholesterol depletion, are con-
sistent with this explanation. In addition, preliminary
experiments on the effects of cholesterol depletion on
Ca21 mobilization by antigen indicate that this activity is
inhibited less than is stimulated tyrosine phosphorylation
of FceRI, consistent with differential effects of cholesterolThe Journal of Cell Biology, Volume 145, 1999 886
depletion on different signaling steps (Holowka, D., and
E.D. Sheets, unpublished results). Membrane structural
changes involved in exocytosis may also be affected. As
described above, the proportionality of FceRI tyrosine
phosphorylation with the number of receptors cross-
linked in the range of 30–100% does not hold for more
downstream signaling events, as only a small fraction of
FceRI needs to be cross-linked to achieve maximal de-
granulation. In future experiments, it will be interesting
to explore the effects of cholesterol depletion on spe-
cific downstream signaling pathways and exocytic mem-
brane events through bypassing receptor-mediated signal-
ing with alternate means of activation.
The results described here are consistent with the hy-
pothesis that cross-linked IgE–FceRI interact with Lyn-
containing DRM domains on the cell surface and that
these structural interactions are integral to the initiation of
signal transduction. Monomeric FceRI probably interact
dynamically with DRM components, and these transient
complexes may exist in the plasma membrane of unstimu-
lated cells as small clusters similar to those recently de-
scribed for certain GPI-anchored proteins (Friedrichson
and Kurzchalia, 1998; Varma and Mayor, 1998). In this hy-
pothesis, cross-linking of IgE–FceRI on the cell surface
causes them to cluster with DRM components, thereby
creating larger Lo regions containing FceRI and Lyn that
are segregated from more fluid regions of the plasma
membrane. It is likely that most transmembrane proteins
are more readily accommodated by phospholipids in the
more fluid liquid crystalline phase, and these would then
segregate from the Lo regions containing FceRI and DRM
components. For example, the tyrosine phosphatase CD45
is a transmembrane protein that was shown to be largely
excluded from DRMs on T cells (Rodgers and Rose, 1996)
and has been recently shown to negatively regulate the Src
family kinase Lck (D’Oro and Ashwell, 1999). Our mi-
croscopy results (Fig. 4 and Holowka, D., E.D. Sheets, and
B. Baird, manuscript in preparation) indicate that segre-
gated DRM domains occupy a large percentage of the cell
surface (20–50%) as detectable within the limits of optical
resolution, and earlier studies indicated that DRM phos-
pholipids represent a similarly large percentage of plasma
membrane phospholipids (Mescher and Apgar, 1985).
Thus, segregation of certain proteins from others may be
more important for signaling promoted by DRM interac-
tions of cross-linked FceRI and Lyn than an increased lo-
calized concentration of these DRM-associated proteins
within domains.
In our model, cholesterol is an essential component for
the Lo phase, and its 60% reduction, as in the studies pre-
sented here, appears to most greatly affect the association
of the transmembrane protein FceRI and the inner leaflet
component Lyn with DRMs (Figs. 3 and 4). Outer leaflet
DRM components are retained in the low-density, TX-
100–insoluble membrane vesicles (Fig. 3), and they still
maintain a small but detectable association with cross-
linked IgE–FceRI on intact cells (Fig. 4 f and data not
shown), which may reflect the continued presence of an Lo
environment in the outer leaflet under conditions of di-
minished cholesterol. It is possible that sphingomyelin and
other sphingolipids enriched in the outer leaflet of the
plasma membrane (Devaux, 1991) cause a preferential re-
tention of cholesterol in this leaflet of the bilayer under
conditions of limiting cholesterol, since this particular class
of phospholipids may interact preferentially with choles-
terol (Brown, 1998). Thus, cholesterol-dependent associa-
tions at the inner leaflet of the plasma membrane may be
more sensitive to cholesterol depletion than are such inter-
actions in the outer leaflet. As an alternative explanation
for our results, it is possible that cholesterol serves as a
critical boundary lipid for FceRI that facilitates a direct in-
teraction with Lyn. However, this explanation would not
account for the association of these components with
DRMs and the correlation between loss of this structural
association and loss of functional coupling. The involve-
ment of DRMs in functional coupling between FceRI and
Lyn as a means of promoting the proximity of these pro-
teins while excluding transmembrane tyrosine phospha-
tases such as CD45 is an attractive hypothesis that war-
rants further examination.
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